Genetic and epigenetic regulation of vascular smooth muscle cell phenotype and contractility

血管平滑肌细胞表型和收缩性的遗传和表观遗传调控

基本信息

  • 批准号:
    10412926
  • 负责人:
  • 金额:
    $ 38.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-02 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Summary Vascular smooth muscle cell (SMC) differentiation is a very important process during vasculogenesis and angiogenesis, and it is well recognized that alterations in SMC phenotype play a role in the progression of several prominent cardiovascular disease states including atherosclerosis, hypertension, and restenosis. During the previous funding period we used high throughput sequencing and computational biology to study chromatin structure and transcription factor binding in human aortic SMCs on a genome-wide level. Our work has led to the identification of previously unrecognized SMC-selective proteins, to the characterization of genetic mechanisms that regulate SMC contractility and blood pressure, and to novel transcription mechanisms that regulate SMC-specific gene expression. Using mass spec approaches we recently identified the SMC-selective methyltransferase, PRDM6, as a myocardin factor interacting protein and have cell culture and in vivo data that PRDM6 is required for the maintenance of SMC differentiation and blood pressure. Importantly recent human genetic study described PRDM6 coding mutations that cause patent ductus arteriosis, and GWAS have identified a locus in PRDM that was associated with BP regulation and intracranial aneurysm. In Aim 1 we will identify the transcription mechanisms and human genetic variations that regulate PRDM6 the SMC-specific expression of PRDM6. Since the mechanisms by which PRDM6 regulates gene expression are completely unknown, in Aim2 we will use genome-wide approaches to identify direct PRDM6 targets, and we will test whether PRDM6 regulates MRTF-A activity by direct methylation. In Aim 3 we will continue to evaluate the contributions of PRDM6 to the regulation of blood pressure and SMC phenotype in vivo using our conditional SMC-specific PRDM6 knockout mice. We have also established collaborations with clinical cardiovascular research teams at the University of North Carolina to begin to examine the correlation between PRDM6 genotype and hypertension in local populations.
总结 血管平滑肌细胞(SMC)的分化是血管发生和分化的重要过程, 血管生成,并且众所周知SMC表型的改变在血管生成的进展中起作用。 几种主要的心血管疾病状态,包括动脉粥样硬化、高血压和再狭窄。 在之前的资助期间,我们使用高通量测序和计算生物学来研究 全基因组水平上的人类主动脉平滑肌细胞的染色质结构和转录因子结合。我们的工作 导致了以前未被识别的SMC选择性蛋白的鉴定, 调节SMC收缩性和血压的遗传机制,以及新的转录 调节SMC特异性基因表达的机制。利用质谱分析方法,我们最近发现 SMC-选择性甲基转移酶,PRDM 6,作为心肌素因子相互作用蛋白,具有细胞培养物 以及体内数据表明PRDM 6是维持SMC分化和血压所必需的。 重要的是,最近的人类遗传学研究描述了导致导管未闭的PRDM 6编码突变 GWAS已经确定了PRDM中与血压调节和颅内动脉硬化相关的位点, 动脉瘤在目标1中,我们将确定转录机制和人类遗传变异, PRDM 6是SMC特异性表达的PRDM 6。由于PRDM 6调节基因的机制 表达是完全未知的,在Aim 2中,我们将使用全基因组方法来识别直接PRDM 6 我们将测试PRDM 6是否通过直接甲基化调节MRTF-A活性。在目标3中, 继续评估PRDM 6对血压和SMC表型调节的贡献, 体内使用我们的条件SMC特异性PRDM 6敲除小鼠。我们还与 北卡罗来纳州大学的临床心血管研究小组开始研究 PRDM 6基因型与当地人群高血压的关系。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.
  • DOI:
    10.1016/j.pharmthera.2018.09.001
  • 发表时间:
    2019-01
  • 期刊:
  • 影响因子:
    13.5
  • 作者:
    Dee RA;Mangum KD;Bai X;Mack CP;Taylor JM
  • 通讯作者:
    Taylor JM
RBPJ binds to consensus and methylated cis elements within phased nucleosomes and controls gene expression in human aortic smooth muscle cells in cooperation with SRF.
RBPJ 与定相核小体内的共有元件和甲基化顺式元件结合,并与 SRF 配合控制人主动脉平滑肌细胞中的基因表达。
  • DOI:
    10.1093/nar/gky617
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Rozenberg,JulianM;Taylor,JoanM;Mack,ChristopherP
  • 通讯作者:
    Mack,ChristopherP
A Primer on Repeated Sitting Exposure and the Cardiovascular System: Considerations for Study Design, Analysis, Interpretation, and Translation.
  • DOI:
    10.3389/fcvm.2021.716938
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Stoner L;Barone Gibbs B;Meyer ML;Fryer S;Credeur D;Paterson C;Stone K;Hanson ED;Kowalsky RJ;Horiuchi M;Mack CP;Dave G
  • 通讯作者:
    Dave G
Prdm6 drives ductus arteriosus closure by promoting ductus arteriosus smooth muscle cell identity and contractility.
  • DOI:
    10.1172/jci.insight.163454
  • 发表时间:
    2023-03-08
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Zou, Meng;Mangum, Kevin D.;Magin, Justin C.;Cao, Heidi H.;Yarboro, Michael T.;Shelton, Elaine L.;Taylor, Joan M.;Reese, Jeff;Furey, Terrence S.;Mack, Christopher P.
  • 通讯作者:
    Mack, Christopher P.
Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher P. Mack其他文献

GRAF1 deficiency leads to defective brown adipose tissue differentiation and thermogenic response
  • DOI:
    10.1038/s41598-024-79301-6
  • 发表时间:
    2024-11-20
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Xue Bai;Qiang Zhu;Matthew Combs;Martin Wabitsch;Christopher P. Mack;Joan M. Taylor
  • 通讯作者:
    Joan M. Taylor

Christopher P. Mack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher P. Mack', 18)}}的其他基金

Atheroprotection by smooth muscle selective RhoGAPs
平滑肌选择性 RhoGAP 的动脉粥样硬化保护作用
  • 批准号:
    10540001
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
Atheroprotection by smooth muscle selective RhoGAPs
平滑肌选择性 RhoGAP 的动脉粥样硬化保护作用
  • 批准号:
    10670403
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
  • 批准号:
    8297230
  • 财政年份:
    2012
  • 资助金额:
    $ 38.88万
  • 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
  • 批准号:
    8644311
  • 财政年份:
    2012
  • 资助金额:
    $ 38.88万
  • 项目类别:
Epigenetic regulation of vascular smooth muscle cell phenotype
血管平滑肌细胞表型的表观遗传调控
  • 批准号:
    8452086
  • 财政年份:
    2012
  • 资助金额:
    $ 38.88万
  • 项目类别:
Molecular regulation of the myocardin factors in vascular smooth muscle
血管平滑肌心肌素因子的分子调控
  • 批准号:
    7860582
  • 财政年份:
    2009
  • 资助金额:
    $ 38.88万
  • 项目类别:
Molecular regulation of the myocardin factors in vascular smooth muscle
血管平滑肌心肌素因子的分子调控
  • 批准号:
    7583535
  • 财政年份:
    2009
  • 资助金额:
    $ 38.88万
  • 项目类别:
Regulation of Smooth Muscle Cell Differentiation by RhoA
RhoA 对平滑肌细胞分化的调节
  • 批准号:
    6747567
  • 财政年份:
    2002
  • 资助金额:
    $ 38.88万
  • 项目类别:
Pre-doctoral Training Program in Integrative Vascular Biology
综合血管生物学博士前培训项目
  • 批准号:
    9210167
  • 财政年份:
    2002
  • 资助金额:
    $ 38.88万
  • 项目类别:
Pre-doctoral Training Program in Integrative Vascular Biology
综合血管生物学博士前培训项目
  • 批准号:
    9902485
  • 财政年份:
    2002
  • 资助金额:
    $ 38.88万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了